About
About Avecho
Board & Leadership
TPM
®
Technology
Portfolio
Pipeline
Phase III Trial
Cannabinoids
Pharmaceutical
Animal Health
Manufacturing
Invest
Investor Centre
Media Centre
Contact
Hit enter to search or ESC to close
Appendix 4E Preliminary Final Financial Report
February 26, 2015
Click here to read more
Post navigation
Previous Post
Phosphagenics Decides to put its BioElixia Cosmetics Brand up for Sale
Next Post
Phosphagenics signs license agreement to expand TPM®-based animal nutrition products to the UK and Ireland
Related Posts
2015 Annual Report
April 15, 2016
June 2017 Half Year Financial Report and Appendix 4D
September 1, 2017
Quarterly Activities Report and 4C – to 31 March 2023
April 28, 2023
May 20, 2023